Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 31.47 | N/A |
| PEG Ratio (TTM) | 43.54 | N/A |
| P/S Ratio (TTM) | 3.98 | N/A |
| P/B Ratio (TTM) | 5.02 | N/A |
| P/FCF Ratio (TTM) | 30.18 | N/A |
| Price to 5YR AVG Earnings Ratio | 34.97 | N/A |
| Price to 5YR AVG FCF Ratio | 50.68 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.19% | N/A |
| ROE (TTM) | 16.57% | N/A |
| Net Profit Margin (TTM) | 12.68% | N/A |
| ROIC 5YR AVG | 8.79% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 6.18% | 20.45% | 520.38% |
| Revenue | 4.24% | 20.04% | 16.39% |
| Net Income | 14.86% | 1.62% | 584.34% |
| Cash Flow | 3.66% | 33.10% | 33.85% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.93 | N/A |
| Quick Ratio (TTM) | 0.71 | N/A |
| D/E Ratio (TTM) | 0.74 | N/A |
| Interest Coverage (TTM) | 5.35 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 2.74 | N/A |
| LTL to 5YR AVG FCF | 5.73 | N/A |
| Shares Outstanding Growth 5YR AVG | 13.91% | N/A |